Navigation Links
Generex Announces Particulars of Conference Call with Members of the Antigen Express Scientific Advisory Board
Date:7/12/2013

n of T-helper cells and prevents the further growth of cancer cells. For more information, visit the Generex website at www.generex.com or the Antigen Express website at www.antigenexpress.com.

Cautionary Note Regarding Forward-Looking Statements

This release and oral statements made from time to time by Generex representatives in respect of the same subject matter may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by introductory words such as "expects," "plan," "believes," "will," "achieve," "anticipate," "would," "should," "subject to" or words of similar meaning, and by the fact that they do not relate strictly to historical or current facts. Forward-looking statements frequently are used in discussing potential product applications, potential collaborations, product development activities, clinical studies, regulatory submissions and approvals, and similar operating matters. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known and others of which are not. Known risks and uncertainties include those identified from time to time in the reports filed by Generex with the Securities and Exchange Commission, which should be considered together with any forward-looking statement. No forward-looking statement is a guarantee of future results or events, and one should avoid placing undue reliance on such statements. Generex undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise. Generex cannot be sure when or if it will be permitted by regulatory agencies to undertake additional clinical trials or to commence any particular phase of clin
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Generex Announces Scheduling of USFDA End-of-Phase II Meeting for the AE37 Breast Cancer Vaccine
2. Generex Enhances Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine with Renowned Breast Cancer Researchers
3. Generex Announces Date of Annual Stockholders Meeting
4. Generex Subsidiary Antigen Express Announces Press Conference at American Association for Cancer Research Related to the Immunological Response of its AE37 Vaccine to Prevent Recurrence of Breast Cancer
5. Generex Announces Patent Award for its Core Vaccine Technologies in Japan
6. Generex Secures Commitments for $3.6M Capital Raise
7. Generex Subsidiary Antigen Express Provides Update on AE37 Cancer Vaccines Clinical & Regulatory Strategy
8. Breast Cancer Vaccine Being Developed by Generex Subsidiary Antigen Express to be Featured on Bloomberg Television Today
9. Leading Investigator to Present Clinical Data on Generex Oral-lyn™ at International Diabetes Federation Meetings in Dubai
10. Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program
11. Averica Discovery Announces Winner of First Averica Award for Supercritical Fluid Chromatography (SFC)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/11/2014)... Until recently, pets suffering from arthritic ailments ... their pain. Pill therapies are costly, can be harmful ... , The procedure uses adult (not embryonic) animal ... regenerative healing power. MediVet's equipment enable veterinarians to remove ... stem cells, then activate and inject the cells into ...
(Date:9/11/2014)... 11, 2014  Ikonopedia will showcase its new ... imaging reporting modules here at the Intensive Breast ... Ikonopedia,s revolutionary suite of report generation software tools ... they look like rather than what they are ... reporting efficiency, and optimize facility operations.  ...
(Date:9/11/2014)... Florida (PRWEB) September 11, 2014 Central ... to announce his partnerships with several Brevard County animal ... Dr. Christiansen has been working in the area since ... small animals since 2008, and is happy to now ... the years Dr. Christiansen has used stem cell therapy ...
(Date:9/10/2014)... Jersey (PRWEB) September 11, 2014 ... its annual Innovations in Dermatological Sciences conference Oct. ... focus on how the university, industry and government ... into clinical use. , This conference is unique ... with cross-sector collaboration, to share their successes, best-practices, ...
Breaking Biology Technology:MediVet America Secures Exclusive Worldwide License with Nanofiber Veterinary 2Ikonopedia Showcases New MQSA Management System and Reporting Modules at Intensive Breast Ultrasound Meeting 2Ikonopedia Showcases New MQSA Management System and Reporting Modules at Intensive Breast Ultrasound Meeting 3Dr. Jeff Christiansen is Now Offering Stem Cell Therapy for Pets at Five Brevard County Animal Hospitals and Beyond 2Dr. Jeff Christiansen is Now Offering Stem Cell Therapy for Pets at Five Brevard County Animal Hospitals and Beyond 3Innovations in Dermatological Sciences 2014 2Innovations in Dermatological Sciences 2014 3
... BioCryst,Pharmaceuticals, Inc. (Nasdaq: BCRX ) today announced that ... will present,a corporate update at the JMP Healthcare Focus ... 10:00 a.m. Eastern Time., A link to a ... accessed on,the BioCryst Web site http://www.biocryst.com . The ...
... Second FDA Cleared Diagnostic Test in 2008; Test, Improves Time-to-Result by ... ... Methods, SUNNYVALE, Calif., Oct. 1 Cepheid (Nasdaq:,CPHD) today announced ... market its Xpert(TM) MRSA/SA Blood Culture (BC),test, which runs on the GeneXpert(R) ...
... Limited,(LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company,announces ... General,Meeting on September 24, 2008, the Company has changed ... Shire plc,s ticker symbols on the London Stock Exchange ... shares and American Depositary,Shares will remain unchanged., Notes ...
Cached Biology Technology:BioCryst to Present at the JMP Healthcare Focus Conference 2BioCryst to Present at the JMP Healthcare Focus Conference 3Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures 2Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures 3Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures 4Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures 5
(Date:9/11/2014)... associate professor of mechanical engineering at Worcester ... the university,s Integrative Materials Design Center (iMdc), ... the National Science Foundation (NSF) to support ... manufacture metal-ceramic composites, which can be used ... efficient, while significantly increasing their performance. , ...
(Date:9/11/2014)... , Sept. 11, 2014 /PRNewswire-iReach/ -- Today at the ... a patient portal that puts genome sequencing results at ... useful and actionable. The $1000 was announced ... many to be the tipping point towards widespread adoption ... 6 billion letters and 4 million variants per human ...
(Date:9/11/2014)... has estimated the total mass of oil that reached the ... Deepwater Horizon blowout. It,s the first time such an estimate ... issue of Environmental Science and Technology . , ... Gulf shoreline in 2010. This finding will help officials determine ... harm to the ecosystem. , The study was conducted by ...
Breaking Biology News(10 mins):NSF funds new method for making materials that can make lighter, more efficient vehicles 2NSF funds new method for making materials that can make lighter, more efficient vehicles 3Tute Genomics Launches MyGene Portal for Genome-guided Medicine 2Tute Genomics Launches MyGene Portal for Genome-guided Medicine 3NJIT researchers working to safeguard the shoreline 2
... a person this is the greatest of pleasures. But, in ... beer as it is among the most energy-intensive foodstuffs during ... working hard to improve the energy balance of the amber ... would allow energy savings of up to 20% during brewing. ...
... pollution, or smog, is a highly reactive, colorless gas ... pollution is most often associated with outdoor air, the ... Ozone can be released by ordinary copy machines, laser ... all of which contribute to increased indoor ozone levels. ...
... Researchers in Australia are developing diversionary tactics to ... those responsible for major gut infections, such as cholera, ... to complex sugar receptors displayed on the surface of ... Society for General Microbiology,s meeting at Heriot-Watt University, Edinburgh, ...
Cached Biology News:Environmentally 'green' beer: Munich brewing engineers research energy savings 2Environmentally 'green' beer: Munich brewing engineers research energy savings 3Houseplants cut indoor ozone 2Designing probiotics that ambush gut pathogens 2
Anti-Indolamine (Indoleamine) 2,3-dioxygenase Immunogen: Recombinant human IDO. Available Date: 38454...
Anti-Ephrin B1 Host: rabbit polyclonal Species Reactivity: human Applications: WB Storage: 4C...
Human Regulatory T cell Staining Kit #2 (w/ APC Foxp3 PCH101, FITC CD4, PE CD25)...
...
Biology Products: